Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,715 | -17,434 | 18,691 | -33,277 | -45,738 |
| Depreciation Amortization | N/A | N/A | N/A | 2,770 | 2,459 |
| Accounts receivable | 387 | N/A | N/A | -2,624 | -1,813 |
| Accounts payable and accrued liabilities | 1,260 | 2,238 | -2,245 | -4,208 | 7,049 |
| Other Working Capital | 3,816 | -193 | -3,149 | -33,370 | 30,525 |
| Other Operating Activity | 11,246 | 4,549 | -27,000 | 10,777 | -142 |
| Operating Cash Flow | $-25,006 | $-10,840 | $-13,703 | $-59,932 | $-7,660 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -1,041 | -949 |
| Purchase Of Investment | N/A | N/A | N/A | -48,395 | N/A |
| Sale Of Investment | N/A | N/A | N/A | 28,200 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-21,236 | $-949 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 18,433 | N/A | N/A | N/A |
| Common Stock Issued | 763 | N/A | N/A | 7,214 | 59,127 |
| Other Financing Activity | -1,423 | 68,656 | 5,000 | 0 | 0 |
| Financing Cash Flow | $-660 | $87,089 | $5,000 | $7,214 | $59,127 |
| Exchange Rate Effect | 46 | 3 | N/A | -5,175 | -3,190 |
| Beginning Cash Position | 83,602 | 7,350 | 16,053 | 117,764 | 70,436 |
| End Cash Position | 57,982 | 83,602 | 7,350 | 38,635 | 117,764 |
| Net Cash Flow | $-25,620 | $76,252 | $-8,703 | $-79,129 | $47,328 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,006 | -10,840 | -13,703 | -59,932 | -7,660 |
| Capital Expenditure | N/A | N/A | N/A | -1,041 | -949 |
| Free Cash Flow | -25,006 | -10,840 | -13,703 | -60,973 | -8,609 |